HESI RN PAIN MANAGEMENT ACCURATE
COMPREHENSIVE PRACTICE EXAM WITH ALL
POSSIBLE APPROVED WELL ELABORATED
PRACTICE QUESTIONS AND 100% CORRECT
VERIFIED ANSWERS WITH DETAILED RATIONALES
PLUS EXPERT ANSWER KEY (100% CORRECT
VERIFIED SOLUTIONS) 2026-2027 CURRENTLY
UPDATED VERSION Q&A GUARANTEED PASS A+
INSTANT DOWNLOAD PDF
1. A patient with chronic back pain reports taking
oxycodone 10 mg every 4 hours for 3 months. Which
assessment finding indicates the need for a
breakthrough pain medication?
A. Pain rating of 4/10 at rest
B. Pain rating of 8/10 after physical therapy
C. Constipation and drowsiness
,D. Nausea with oral intake
B. Pain rating of 8/10 after physical therapy
Breakthrough pain is transient exacerbation of
pain that occurs despite stable around-the-clock
opioid therapy. A pain rating of 8/10 after activity
indicates breakthrough pain requiring immediate-
release rescue medication. Rest pain of 4/10 is
well-controlled, and constipation/drowsiness are
side effects, not breakthrough pain indicators.
2. The nurse is assessing a patient who just returned
from surgery. Which pain assessment tool is most
appropriate for a patient who is alert but unable to
speak due to an endotracheal tube?
A. Numeric Rating Scale (0-10)
B. Visual Analog Scale
C. Wong-Baker FACES Pain Rating Scale
D. Behavioral Pain Scale
C. Wong-Baker FACES Pain Rating Scale
The Wong-Baker FACES scale uses facial
expressions to rate pain and requires minimal
,verbal ability, making it ideal for patients with an
endotracheal tube who cannot speak. The Numeric
and Visual Analog scales require verbal or written
responses. The Behavioral Pain Scale is for
unresponsive patients.
3. A patient with terminal cancer receives morphine
sulfate extended-release 60 mg every 12 hours. The
patient requests additional medication for pain.
Which action is most appropriate?
A. Administer an additional 60 mg of extended-
release morphine
B. Administer immediate-release morphine 10 mg
PO
C. Withhold pain medication until the next
scheduled dose
D. Administer naloxone to reverse respiratory
depression
B. Administer immediate-release morphine 10 mg
PO
Extended-release opioids are for chronic pain
, management and should not be given more
frequently. Breakthrough pain is treated with
immediate-release opioids at doses typically 10-
15% of the total daily opioid dose. Naloxone is not
indicated unless respiratory depression occurs.
4. Which patient is at highest risk for opioid-induced
respiratory depression?
A. A 25-year-old with acute appendicitis receiving
morphine 4 mg IV
B. A 60-year-old with COPD receiving
hydromorphone 2 mg IV
C. A 40-year-old with renal failure receiving fentanyl
patch 25 mcg/hr
D. A 75-year-old with osteoarthritis receiving
acetaminophen 1000 mg PO
B. A 60-year-old with COPD receiving
hydromorphone 2 mg IV
Patients with COPD have impaired respiratory
reserve and are at increased risk for respiratory
depression from opioids. Age >60, renal failure,
COMPREHENSIVE PRACTICE EXAM WITH ALL
POSSIBLE APPROVED WELL ELABORATED
PRACTICE QUESTIONS AND 100% CORRECT
VERIFIED ANSWERS WITH DETAILED RATIONALES
PLUS EXPERT ANSWER KEY (100% CORRECT
VERIFIED SOLUTIONS) 2026-2027 CURRENTLY
UPDATED VERSION Q&A GUARANTEED PASS A+
INSTANT DOWNLOAD PDF
1. A patient with chronic back pain reports taking
oxycodone 10 mg every 4 hours for 3 months. Which
assessment finding indicates the need for a
breakthrough pain medication?
A. Pain rating of 4/10 at rest
B. Pain rating of 8/10 after physical therapy
C. Constipation and drowsiness
,D. Nausea with oral intake
B. Pain rating of 8/10 after physical therapy
Breakthrough pain is transient exacerbation of
pain that occurs despite stable around-the-clock
opioid therapy. A pain rating of 8/10 after activity
indicates breakthrough pain requiring immediate-
release rescue medication. Rest pain of 4/10 is
well-controlled, and constipation/drowsiness are
side effects, not breakthrough pain indicators.
2. The nurse is assessing a patient who just returned
from surgery. Which pain assessment tool is most
appropriate for a patient who is alert but unable to
speak due to an endotracheal tube?
A. Numeric Rating Scale (0-10)
B. Visual Analog Scale
C. Wong-Baker FACES Pain Rating Scale
D. Behavioral Pain Scale
C. Wong-Baker FACES Pain Rating Scale
The Wong-Baker FACES scale uses facial
expressions to rate pain and requires minimal
,verbal ability, making it ideal for patients with an
endotracheal tube who cannot speak. The Numeric
and Visual Analog scales require verbal or written
responses. The Behavioral Pain Scale is for
unresponsive patients.
3. A patient with terminal cancer receives morphine
sulfate extended-release 60 mg every 12 hours. The
patient requests additional medication for pain.
Which action is most appropriate?
A. Administer an additional 60 mg of extended-
release morphine
B. Administer immediate-release morphine 10 mg
PO
C. Withhold pain medication until the next
scheduled dose
D. Administer naloxone to reverse respiratory
depression
B. Administer immediate-release morphine 10 mg
PO
Extended-release opioids are for chronic pain
, management and should not be given more
frequently. Breakthrough pain is treated with
immediate-release opioids at doses typically 10-
15% of the total daily opioid dose. Naloxone is not
indicated unless respiratory depression occurs.
4. Which patient is at highest risk for opioid-induced
respiratory depression?
A. A 25-year-old with acute appendicitis receiving
morphine 4 mg IV
B. A 60-year-old with COPD receiving
hydromorphone 2 mg IV
C. A 40-year-old with renal failure receiving fentanyl
patch 25 mcg/hr
D. A 75-year-old with osteoarthritis receiving
acetaminophen 1000 mg PO
B. A 60-year-old with COPD receiving
hydromorphone 2 mg IV
Patients with COPD have impaired respiratory
reserve and are at increased risk for respiratory
depression from opioids. Age >60, renal failure,
